Daxor Corporation (DXR) vs Stereotaxis Inc. (STXS)

Daxor Corporation and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Stereotaxis Inc. is the larger, with a market value of $133.3M against $66.5M — 2.0× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Daxor Corporation trades at 5.1×. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −52.1%. Stereotaxis Inc. has the higher net margin (−78.5% vs −251.9%) and the lower return on invested capital (−203.6% vs 0.00%). Across the 16 metrics below, Daxor Corporation leads on 10 and Stereotaxis Inc. on 6.

Valuation

Metric DXR STXS Medical Instruments & Supplies median
P/E 5.12 n/m 34.17
P/S n/m 4.32 2.83
P/B 1.62 10.62 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales (15.67) 4.16 3.06
Earnings yield 19.53% (18.46%) (1.84%)
Free cash flow yield (15.30%) (11.92%) 0.17%

Profitability

Metric DXR STXS Medical Instruments & Supplies median
Gross margin 0.00% 55.57% 54.62%
Operating margin 0.00% (75.68%) 1.64%
Net margin (251.91%) (78.45%) 0.00%
Free cash flow margin 224.51% (51.56%) 1.61%
Return on equity 37.62% (344.36%) 0.00%
Return on assets 35.90% (48.76%) 0.00%
Return on invested capital 0.00% (203.58%) 0.00%

Growth

Metric DXR STXS Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) (5.46%) 9.20%
EPS growth (last fiscal year) 7.63% 16.67% —
Revenue growth, 5-year CAGR 0.00% 3.99% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR STXS Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 1.66 1.42 2.49
Net debt to EBITDA 0.00 0.65 0.83

Dividend

Metric DXR STXS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric DXR STXS Medical Instruments & Supplies median
Market cap 66.52m 133.27m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack